InspireMD Announces Expected Retirement of its CFO Craig Shore and CFO Transition in 2025
MIAMI, Dec. 12, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for ...
InspireMD, Inc.: InspireMD Announces Expected Retirement of its CFO Craig Shore and CFO ...
InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that Craig Shore, ...
Quad-City Times2 小时
High school girls from Iowa, Illinois explore medical careers at "Women in Cardiology"
High school girls connected with a range of local cardiovascular professionals and saw live medical demonstrations.
BMJ13 小时
Doubts over landmark heart drug trial: ticagrelor PLATO study
A top selling antiplatelet drug has never quite shaken off doubts about its advantage over cheaper rivals. With generic versions of ticagrelor about to launch, Peter Doshi takes a fresh look at the ...